Viewing Study NCT00813332


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2025-12-27 @ 1:25 AM
Study NCT ID: NCT00813332
Status: UNKNOWN
Last Update Posted: 2010-01-25
First Post: 2008-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)
Sponsor: Simcere Pharmaceutical Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module